Condition
Central Apnea
Total Trials
4
Recruiting
0
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 65/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Terminated1
Withdrawn1
Active Not Recruiting1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03695900Not ApplicableCompleted
Arterial Oxygen Saturation on Ventilatory Stability in Extremely Premature Infants
NCT03478566Not ApplicableActive Not Recruiting
Transcutaneous CO2 Monitoring at Home for Children With Neuromuscular Disease
NCT01978340Withdrawn
Eval EarlySense Bet Lowenstein Sleeplab
NCT00746954Phase 3TerminatedPrimary
Buspirone as a Potential Treatment for Recurrent Central Apnea
Showing all 4 trials